CSL: Strengthening the R&D network in Switzerland
CSL's R&D department in Switzerland opens a new office in the Innovation Park Basel Area premises. Following the opening of the office at the Biopole campus in Lausanne earlier this year, this is a key milestone in strengthening the R&D network in Switzerland.
The biotech company CSL officially opened its office at the beginning of November in the premises of the Switzerland Innovation Park Basel Area on the Novartis Campus, a meeting place for biotech and healthcare pioneers. This is a key milestone in strengthening CSL's R&D network in Switzerland. It enables flexible and activity-based working and taps the region's great potential for collaboration along the drug development process.
"With this move, we are not only expanding our long-standing strategic partnerships with key biotechnology players in Basel, but also securing access to the region's talent pool and exploring further opportunities for collaboration," said Emmanuelle Lecomte Brisset, head of Global Regulatory Affairs at CSL, who is responsible for the work to strengthen CSL's R&D presence in Switzerland.
The contract with the operator Switzerland Innovation Park Basel Area covers 18 workstations on the Novartis Campus in Basel.
Christof Klöpper, CEO Basel Area Business & Innovation, is delighted about the new addition: "We are proud that such an important life science company as CSL is now part of the community in the Switzerland Innovation Park Basel Area. This is a tremendous enrichment for the Basel Area innovation ecosystem and biotech clusters."
The Switzerland Innovation Park Basel Area is part of the Switzerland Innovation network of science parks and comprises three locations: Allschwil, Jura and Novartis Campus in Basel. Its focus areas are biotech, medtech, digital health, health tech and industrial transformation. Tenants will have access to infrastructure, a community of great talent, and a wide range of services. Around 510 people from 74 companies and 12 research groups currently work at the Basel Area Park, which is managed by Basel Area Business & Innovation.
CSL, with its business units CSL Behring in Bern and CSL Vifor in Zurich, has a healthy and thriving R&D presence in Switzerland with well over 500 employees who are continuously expanding their network and long-standing collaborations with renowned academic institutions and life science organizations in Switzerland and Europe to contribute to the company's global strategic goals.
Source: www.cslbehring.ch
